Greer Ben Dept web

Benjamin E Greer, MD

Professor
Director, SCCA Network
Director, SCCA Division of Gynecologic Oncology

 
Joined UW Medicine:

8/1/80

Clinical Focus:

Gynecologic Oncology:
• Clinical trials for gynecologic malignancies
• Radiation therapy application to gynecologic cancers

Licensure:

• Washington, 1980
• Montana, 2009

Certification:

• Obstetrics and Gynecology, 1972 (recertified 1989)
• Gynecologic Oncology, 1983

Education:

• MD Degree
   (University of Pennsylvania, 1966)
• Residency in Obstetrics and Gynecology
   (University of Colorado Medical Center, 1970)
• Certificate, Management Program
   (University of Washington School of Business Admin, 1991)

Research Interests:

• Clinical trials for gynecologic malignancies
• Radiation therapy application to gynecologic cancers

Memberships:

• American Congress of Obstetricians and Gynecologists
• American Gynecological and Obstetrical Society
• American Society of Clinical Oncology
• Association of Professors of Gynecology and Obstetrics
• Felix Rutledge Society
• Gynecologic Oncology Group (GOG)
• International Gynecologic Cancer Society
• King County Medical Society
• National Comprehensive Cancer Network
• North Dakota Society of Obstetrics and Gynecology (Honorary Member)
• Puget Sound Oncology Consortium
• Society of Gynecologic Oncologists, Vice President
• Seattle Gynecological Society
• Washington State Medical Association
• Western Association of Gynecologic Oncologists (Past President)

Selected Publications:

Greer BE, Abu-Rustyn NR, Campos SM, et al. Clinical practice guidelines in oncology. Cervical cancer. J Natl Compr Cancer Network 2010;8(12):1388-416.

Han ES, Burger RA, Darcy KM, Sill MW, Randall LM, Chase D, Parmakhitar B, Monk BJ, Greer BE. Predictive and prognostic angiogenic markers in a Gynecologic Oncology Group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer. Gynecol Oncol 2010;119(3):484-90.

Farley J, Fuchiuji S, Darcy KM, Tian C, Hoskins WJ, McGuire WP, Hanjani P, Warshal D, Greer BE, et al. Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study. Gynecol Oncol 2009;113(3):341-7.

Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, et al. Clinical practice guidelines in oncology: uterine neoplasms. J Natl Compr Cancer Network 2009;7(5):498-531.

McLean KA, Shah CA, Thompson SA, Gray HJ, Greer BE, Swensen RE, Swisher EM, Tamimi HK, Goff BA. Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction. Gynecol Oncol 2008;111(2):375-6.

Morgan RJ, Jr, Alvarez RD, Armstrong DL, Boston B, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, et al. The NCCN ovarian cancer clinical practice guidelines in oncology. J Natl Compr Cancer Network 2008;6(8):766-94.

Brotto LA, Heiiman JR, Goff B, Greer B, Lentz GM, et al. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer. Arch Sex Behav 2008;37(2):317-29.

Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM, et al. The NCCN cervical cancer screening clinical practice guidelines in oncology. J Natl Compr Cancer Network 2008;6(1):58-82.

Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, et al. The NCCN cervical cancer clinical practice guidelines in oncology, J Natl Compr Cancer Network 2008;6(1):14-36.

Burger RA, Sill MW, Monk BJ, Greer BE, Sorosky JI. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007;25(33):5165-71.

Rose PG, Greer BE, Horowitz IR, Markman M, Fusco N. Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A Phase I study of the Gynecologic Oncology Group. Gynecol Oncol 2007;104(1):114-9.

Morgan RJ Jr, Alvarez RD, Armstrong DK, Chen LM, Copeland L, Fowler J, Gaffney DK, Gershenson D, Greer BE, et al. The NCCN ovarian cancer clinical practice guidelines in oncology. J Natl Compr Cancer Network 2006;4(9):912-39.

Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, et al. The NCCN uterine cancers: clinical practice guidelines in oncology. J Natl Compr Cancer Network 2006;4(5):438-62.

Rajendrean JG, Greer BE. Expanding role of positron emission tomography in cancer of the uterine cervix. J Natl Compr Cancer Network 2006;4(5):463-69.

Swisher EM, Swensen RE, Greer BE, Tamimi HK, Goff BA, Garcia R, Koh WJ. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A Phase I trial of the Puget Sound Oncology Consortium. Gynecol Oncol 2006;101;429-35.

Lachance JA, Everett E, Greer BE, Mandel LS, Swisher E, Tamimi H, Goff BA. The effect of age on clinical pathologic features, surgical morbidity and outcome in patients with endometrial cancer. Gynecol Oncol 2006;101:470-4.

Swisher EM, Swensen RE, Greer BE, Tamimi HK, Goff BA, Garcia R, Koh WJ. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A Phase I Trial of the Puget Sound Oncology Consortium. Gynecol Oncol 2006;101:429-35.

Shah C, Johnson B, Everett E, Tamimi H, Greer B, Swisher E, Goff BA. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol 2005;99(3):564-70.

Greer BE, Bundy BN, Ozols RF, Fowler MJ, Clarke-Pearson D, et al. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study. Gynecol Oncol 2005;99(1)71-9.

Larvey RS, Liu PY, Greer BE, Robinson WR, Chang PC, et al. Recombinant human erythropoietin (EPO) as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. Gynecol Oncol 2004;95(1):145-51.

Larvey RS, Liu PY, Greer BE, Robinson WR, Pui CC, et al. Recombinant human erythropoietin (EPO) as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. Int J Radiat Oncol Biol Phys 2003;57(2 Suppl):S190-1.

Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected Stage III ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol 2003;21(17):3194-200.

Stehman FB, Rose PG, Greer BE, Roy M, Plante M, et al. Innovations in the treatment of invasive cervical cancer. Cancer (Supplement) 2003;98(9):2051-63.

Goff BA, Thompson T, Greer BE, Jacobs A, Storer B. Treatment of recurrent platinum-resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: a Phase I/II trial of the Puget Sound Oncology Consortium. Am J Obstet Gyencol 2003;188(6):1556-6.

Appointments & Practice Locations

Seattle Cancer Care Alliance (SCCA)
1354 Aloha Street, Seattle, WA 98109

Appointments:   206.288.7155 (new patients)
                           206.288.6200 (return pts)